Literature DB >> 17074914

Estimation of the benchmark dose by structural equation models.

Esben Budtz-Jørgensen1.   

Abstract

While epidemiological data typically contain a multivariate response and often also multiple exposure parameters, current methods for safe dose calculations, including the widely used benchmark approach, rely on standard regression techniques. In practice, dose-response modeling and calculation of the exposure limit are often based on the seemingly most sensitive outcome. However, this procedure ignores other available data, is inefficient, and fails to account for multiple testing. Instead, risk assessment could be based on structural equation models, which can accommodate both a multivariate exposure and a multivariate response function. Furthermore, such models will allow for measurement error in the observed variables, which is a requirement for unbiased estimation of the benchmark dose. This methodology is illustrated with the data on neurobehavioral effects in children prenatally exposed to methylmercury, where results based on standard regression models cause an underestimation of the true risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17074914     DOI: 10.1093/biostatistics/kxl037

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  5 in total

1.  A new method for determining the benchmark dose tolerable region and endpoint probabilities for toxicology experiments.

Authors:  Naha J Farhat; Edward L Boone; David J Edwards
Journal:  J Appl Stat       Date:  2019-08-18       Impact factor: 1.416

2.  Structural equation modeling in medical research: a primer.

Authors:  Tanya N Beran; Claudio Violato
Journal:  BMC Res Notes       Date:  2010-10-22

3.  Spline-based procedures for dose-finding studies with active control.

Authors:  Hans-Joachim Helms; Norbert Benda; Jörg Zinserling; Thomas Kneib; Tim Friede
Journal:  Stat Med       Date:  2014-10-16       Impact factor: 2.373

4.  Economic benefits of methylmercury exposure control in Europe: monetary value of neurotoxicity prevention.

Authors:  Martine Bellanger; Céline Pichery; Dominique Aerts; Marika Berglund; Argelia Castaño; Mája Cejchanová; Pierre Crettaz; Fred Davidson; Marta Esteban; Marc E Fischer; Anca Elena Gurzau; Katarina Halzlova; Andromachi Katsonouri; Lisbeth E Knudsen; Marike Kolossa-Gehring; Gudrun Koppen; Danuta Ligocka; Ana Miklavčič; M Fátima Reis; Peter Rudnai; Janja Snoj Tratnik; Pál Weihe; Esben Budtz-Jørgensen; Philippe Grandjean
Journal:  Environ Health       Date:  2013-01-07       Impact factor: 5.984

5.  Point and Interval Estimators of the Target Dose in Clinical Dose-Finding Studies with Active Control.

Authors:  H-J Helms; N Benda; T Friede
Journal:  J Biopharm Stat       Date:  2014-06-11       Impact factor: 1.051

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.